Skip to content

Effect of Yoga therapy in patients with Multiple Sclerosis

Effectiveness of Yoga as an Add-On Treatment in Multiple Sclerosis (YOGA-MS): A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088451
Enrollment
104
Registered
2025-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G35- Multiple sclerosis

Interventions

Intervention1: Yoga and Standard Medical Care: The intervention group will be taught additional yoga practices (as per the protocol enclosed) by institutionally trained yoga therapist at CIMR (Center

Sponsors

All India Institute of Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case Inclusion Criteria 1.A diagnosis of MS using revised McDonald criteria 2017 (appendix) 2.Either RRMS, SPMS or PPMS phenotypes. 3.Males or females, aged between 18 to 50 years 4.Indian origin 5.Fatigue as evaluated using Fatigue severity scale (FSS) with a mean score of 4 and above. 6.EDSS (Expanded Disability Status Scale) score between 0 and 5 (appendix) 7.Written informed consent

Exclusion criteria

Exclusion criteria: Case Exclusion Criteria 1.Enrollment in another trial. 2.Any condition which in the opinion of the investigator would render the patient unsuitable. 3.Any concurrent illness, disability, or clinically significant abnormality (including laboratory tests) that may prevent the subject from safely completing the assessments required by the protocol. 4. Exacerbation of MS within 30 days before study inclusion 5. Botox to lower limbs within 6 months before study 6. Denial of consent

Design outcomes

Primary

MeasureTime frame
Primary outcomes: 1.Improvement on Fatigue severity score between baseline and 3 months. This will be assessed as the mean score change between the intervention and control groups between baseline and 3 months. 2.Proportion of patients who improve to mean FSS below 4 at 3 months Timepoint: Baseline and after 3 months

Secondary

MeasureTime frame
Secondary outcomes: The secondary outcomes will include change in MFIS (Modified fatigue impact score), 25 feet walk test, MSQOL (MS quality of life), SF 36, HAM A (Hamilton Anxiety), HAM D (Hamilton Depression), EDSS ambulation score (Expanded disability status score) between baseline and at 3 months Timepoint: Baseline and after 3 months

Countries

India

Contacts

Public ContactDr Rohit Bhatia

All India Institute of Medical Sciences New Delhi

rohitbhatia71@yahoo.com9891267417

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026